Skip to main content

Pharmacy

By Susan Morse | 10:45 am | September 16, 2019
Sackler family would exit Purdue, pay $3 billion; the company would give more than $10 billion towards opioid overdose reversal medications.
By Jeff Lagasse | 04:27 pm | September 13, 2019
The company saw a market opportunity in helping bring independent pharmacies into the digital and mobile economy.
By Susan Morse | 09:57 am | September 09, 2019
Employers, health plans and unions may enroll; Covered consumers have no out-of-pocket payment for medication.
By Susan Morse | 07:13 pm | September 04, 2019
Arguments against the merger were insufficient to undermine the settlement agreement reached by the Department of Justice, judge says.
By Susan Morse | 03:56 pm | September 04, 2019
Walmart and Walgreens are among pharmacies in new Clearinghouse Model to eliminate drug price variability and lower costs.
By Jeff Lagasse | 04:03 pm | September 03, 2019
From 1980 through 2018, the FDA approved a total of 126 cancer drugs to treat solid and hematologic tumors.
By Jeff Lagasse | 10:25 am | August 28, 2019
From 1992 to 2008, 36% of post-market studies had not been completed, and many took five years to even begin.
By Jeff Lagasse | 04:28 pm | August 27, 2019
Price increases do indeed get passed down to patients, the authors found, and that can negatively impact access.
By Jeff Lagasse | 01:08 pm | August 19, 2019
Pharmaceutical costs are already a large share of most health organizations' budgets and this year's inflation rate may increase drug budgets.
By Susan Morse | 03:35 pm | August 14, 2019
Part D plan sponsors mainly used five PBMs in 2016: CVS Caremark, OptumRx, Express Scripts, Medimpact and Argus.